Delayed, Irregular Sleep Midpoint Affects Belly Fat, BP Link in Teens

MONDAY, March 6, 2023 (HealthDay News) -- For adolescents, a delayed and irregular sleep midpoint during school days and on-break weekdays impacts the association of visceral adipose tissue (VAT) on blood pressure, according to a study published online March 6 in Hypertension.
Natasha Morales-Ghinaglia, from the Penn State University College of Medicine in Hershey, and colleagues studied 303 individuals from the Penn State Child Cohort to examine whether deviations in sleep midpoint modify the association between visceral adiposity and elevated blood pressure in adolescents. Across a seven-night period, actigraphy-measured sleep duration, midpoint, variability, and regularity were calculated.
The researchers observed significant interactions between VAT and sleep irregularity, but not sleep midpoint, on systolic blood pressure (SBP) and diastolic blood pressure (DBP). Significant interactions were also identified between VAT and schooldays sleep midpoint on SBP and DBP, while a significant interaction between VAT and on-break weekdays sleep irregularity was seen for SBP only.
"These data support that an irregular sleep-wake phase, independent of sleep apnea and insufficient sleep, may contribute to the development of cardiovascular sequelae associated with central obesity," the authors write. "Our findings are highly significant from a translational standpoint to public health prevention and clinical care, as they inform behavioral and pharmacological sleep and circadian interventions in youth."
One author reported receiving grants, including from Pfizer.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Pharmacies Must Fill Rx for Drugs That May End Pregnancy, Biden Administration Says
THURSDAY, July 14, 2022 (HealthDay News) -- Pharmacies must fill prescriptions...
El tabaco y el alcohol son drogas de entrada para la marihuana, encuentra un estudio
JUEVES, 30 de septiembre de 2021 (HealthDay News) -- Para las personas que fuman...
Common Diabetes Drug Januvia May Contain Traces of Carcinogen, FDA Says
FRIDAY, Aug. 12, 2022 (HealthDay News) – The popular diabetes drug Januvia may...
Abrocitinib Efficacious for Eczema, Regardless of Dupilumab Response
WEDNESDAY, May 4, 2022 (HealthDay News) -- For patients with moderate-to-severe...
